Navigation Links
Neogen announces Bohannon retirement, successor named

LANSING, Mich., June 10, 2013 /PRNewswire/ -- Neogen Corporation (Nasdaq: NEOG) announced today that Lon Bohannon, the company's President and Chief Operating Officer, has announced his intent to retire effective August 31, 2013. Bohannon has been employed by Neogen for 27 years and has served as the company's Chief Operating Officer since 2000.

"Lon has been a great asset to Neogen as we worked together from a handful of employees to an experienced management team with over 800 employees," said James Herbert, Neogen's Chairman and CEO.  "Lon indicated his desire to retire a number of months ago, which made it possible for he and I to work closely in the selection of his replacement."

Neogen also announced the naming of Stephen Snyder as President and Chief Operating Officer Elect to replace Bohannon. Snyder comes to Neogen with 26 years' experience in leadership roles with both Monsanto and Cargill. His most recent position has been Vice President of Marketing for the Industrial Oils and Lubricants business of Cargill. Earlier, he was Vice President and Global Business Director for Cargill's Health and Nutrition business, where he was involved in launching the stevia-based natural sweetener business. Most of his career has been devoted to technical, financial, and marketing activities of food related businesses.

"Steve's background will fit well with our organization and he will have a few months to work with Lon in the transition," said Herbert. "Steve's background, including a chemistry degree and a Harvard MBA, makes him uniquely qualified since he already has a good understanding of our technology and a relationship with many of Neogen's customers."

Neogen Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets diagnostic test kits to detect foodborne bacteria, natural toxins, genetic modifications, food allergens, drug residues, meat speciation, plant diseases, and sanitation concerns, and dehydrated culture media. Neogen's Animal Safety Division is a leader in the development of animal genomics, along with the manufacturing and distribution of a variety of animal healthcare products, including diagnostics, pharmaceuticals, veterinary instruments, wound care and disinfectants.


Steven J. Quinlan, Vice President & CFO

Neogen Corporation


SOURCE Neogen Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Neogen Corporation Announces 2nd Quarter Results Conference Call
2. Neogen Reports Second Quarter Results
3. Neogen Launches Fully Quantitative Lateral Flow Test for DON
4. Neogen launches the fastest molecular pathogen test
5. Neogen acquires Igenity from Merial
6. Neogen Corporation Announces Year-End Results Conference Call
7. Neogen reports year end results
8. Neogen Corporation Announces 1st Quarter Results Conference Call
9. Neogen reports 30% increase in quarterly net income
10. Neogen Corporation Announces 3rd Quarter Results Conference Call
11. Neogen launches rapid tests for ractopamine
Post Your Comments:
(Date:11/24/2015)... Switzerland (PRWEB) , ... November 24, 2015 , ... ... plant and the environment are paramount. Insertion points for in-line sensors can represent ... has developed the InTrac 781/784 series of retractable sensor housings , which ...
(Date:11/24/2015)... , Nov. 24, 2015 HemoShear ... on discovering drugs for metabolic disorders, announced today ... to its Board of Directors (BOD). Mr. Watkins ... of Human Genome Sciences (HGS), and also served ... Jim Powers , Chairman and CEO ...
(Date:11/23/2015)... , Nov. 24, 2015 Women with a ... CT exams face a higher risk of lung cancer than ... presented next week at the annual meeting of the Radiological ... --> --> Lung nodules ... classified as solid or subsolid based on their appearance on ...
(Date:11/23/2015)... The royalty-free a greement a llows ... 112 low- and m iddle-i ncome ... --> The Medicines Patent Pool (MPP) today announced its ... with Bristol-Myers Squibb for daclatasvir, a novel direct-acting antiviral that ... virus.  The royalty-free licence will enable generic manufacture of daclatasvir ...
Breaking Biology Technology:
(Date:11/12/2015)... Nov. 12, 2015  A golden retriever that stayed ... dystrophy (DMD) has provided a new lead for treating ... the Broad Institute of MIT and Harvard and the ... . Cell, pinpoints a protective ... the disease,s effects. The Boston Children,s lab of ...
(Date:11/10/2015)... , Nov. 10, 2015  In this ... the basis of product, type, application, disease ... in this report are consumables, services, software. ... are safety biomarkers, efficacy biomarkers, and validation ... report are diagnostics development, drug discovery and ...
(Date:11/4/2015)... York , November 4, 2015 ... a new market report published by Transparency Market Research "Home ... Growth, Trends and Forecast 2015 - 2022", the global home ... US$ 30.3 bn by 2022. The market is estimated ... forecast period from 2015 to 2022. Rising security needs ...
Breaking Biology News(10 mins):